You are here

Article Text

Article menu

other Versions

Download PDFPDF

Technical video
Transvenous arteriovenous malformation embolization
  1. Bledi C Brahimaj1,
  2. Kiffon Keigher2,
  3. Demetrius Klee Lopes2
  1. 1Neurosurgery, Rush University Medical Center, Chicago, Illinois, USA
  2. 2Department of Neurosurgery, Advocate Aurora Health, Chicago, Illinois, USA
  1. Correspondence to Dr Demetrius Klee Lopes; brainaneurysm{at}mac.com

https://doi.org/10.1136/neurintsurg-2019-015515

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Abstract

    Transvenous embolization of arteriovenous malformations has emerged as a safe and effective intervention.1,2 In carefully selected patients the transvenous approach has shown efficacy similar to that of conventional transarterial routes.3,4,5 The optimal lesions amenable to the transvenous approach have not been robustly delineated; however, the approach is reserved for small, deep seeded, single venous drainage lesions with poorly amenable arterial vascular supply.6 7,8 In this video we demonstrate a case of transvernous Onyx embolization of a Spetzler-Martin grade 3 (SM3) left hemispheric, ruptured arteriovenous malformation. The patient underwent successful, single session, complete embolization of the arteriovenous malformation through a venous route without further complications or repeat treatment.

    Video 1

    References

    1. ↵
      1. Albuquerque FC,
      2. Ducruet AF,
      3. Crowley RW, et al
      . Transvenous to arterial Onyx embolization. J Neurointerv Surg2014;6:281–5.doi:10.1136/neurintsurg-2012-010628
      OpenUrlAbstract/FREE Full Text
    2. ↵
      1. Lopes DK,
      2. Bagan B,
      3. Wells K
      . Onyx embolization of arteriovenous malformations using 2 microcatheters. Neurosurgery2010;66:616–9. discussion 618-619.doi:10.1227/01.NEU.0000365368.08451.08
      OpenUrlCrossRefPubMed
    3. ↵
      1. Consoli A,
      2. Renieri L,
      3. Nappini S, et al
      . Endovascular treatment of deep hemorrhagic brain arteriovenous malformations with transvenous onyx embolization. AJNR Am J Neuroradiol2013;34:1805–11.doi:10.3174/ajnr.A3497
      OpenUrlAbstract/FREE Full Text
    4. ↵
      1. Iosif C,
      2. Mendes GAC,
      3. Saleme S, et al
      . Endovascular transvenous cure for ruptured brain arteriovenous malformations in complex cases with high Spetzler-Martin grades. J Neurosurg2015;122:1229–38.doi:10.3171/2014.9.JNS141714
      OpenUrlCrossRefPubMed
    5. ↵
      1. Kessler I,
      2. Riva R,
      3. Ruggiero M, et al
      . Successful transvenous embolization of brain arteriovenous malformations using Onyx in five consecutive patients. Neurosurgery2011;69:184–93. discussion 193.doi:10.1227/NEU.0b013e318212bb34
      OpenUrlCrossRefPubMed
    6. ↵
      1. Martínez-Galdámez M,
      2. Saura P,
      3. Saura J, et al
      . Transvenous Onyx embolization of a subependymal deep arteriovenous malformation with a single drainage vein: technical note. J Neurointerv Surg2014;6:e20.doi:10.1136/neurintsurg-2012-010603.rep
    7. ↵
      1. Mendes GAC,
      2. Iosif C,
      3. Silveira EP, et al
      . Transvenous embolization in pediatric plexiform arteriovenous malformations. Neurosurgery2016;78:458–65.doi:10.1227/NEU.0000000000001057
      OpenUrl
    8. ↵
      1. Renieri L,
      2. Limbucci N,
      3. Consoli A, et al
      . Transvenous embolization: a report of 4 pediatric cases. J Neurosurg Pediatr2015;15:445–50.doi:10.3171/2014.11.PEDS13437
      OpenUrlCrossRefPubMed
      1. Chen C-J,
      2. Norat P,
      3. Ding D, et al
      . Transvenous embolization of brain arteriovenous malformations: a review of techniques, indications, and outcomes. Neurosurg Focus2018;45:E13.doi:10.3171/2018.3.FOCUS18113

    Footnotes

    • Contributors All authors contributed to the current work equally.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests DL is a speaker, proctor, receives research grants and is an advisor for Medtronic.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; externally peer reviewed.